Proton therapy for early stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a precise form of proton radiation for people with early stage lung cancer who cannot have surgery. It aims to see if this treatment is effective and safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lung cancer confirmed by a biopsy or by two different scans and a team of doctors agrees.
- Your cancer is early stage (IA to IIB) and has not spread to lymph nodes or other parts of the body.
- You are 18 years or older.
- You are able to care for yourself (KPS score of 60 or higher).
- Surgery is not an option for you, or you choose not to have it.
- Your blood counts and kidney/liver function are within normal limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a more precise radiation technique (stereotactic body radiotherapy) for early-stage lung cancer or small lung tumors. It aims to reduce side effects by eliminating the usual safety margin around the tumor.
This trial tests a new type of proton radiation for early-stage non-small cell lung cancer. It aims to see if it's safe and works well, with less damage to healthy tissue.
This study tests whether a single, very high-dose focused radiation treatment can control early-stage lung cancer. It may help people who can’t or prefer not to have surgery, by delivering precise radiation to the tumor while aiming to spare nearby tissue.
This trial tests if proton beam radiation therapy is safe and effective after surgery for non-small cell lung cancer that has spread to lymph nodes in the chest. It is for people who have already had chemotherapy before their surgery.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This trial studies how detailed tests (“multi-omics” modeling) can improve how doctors plan and deliver stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer. It may help make treatment planning more precise for cancers in stages I–II.
Hear when a new Early-Stage Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.